Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for acute myeloid leukemia with t(9;11)(p22;q23).
6 publications have been identified in PubMed for acute myeloid leukemia with t(9;11)(p22;q23). Research spans Gene Therapy / Novel Therapeutics (33%), Review / Meta-Analysis (17%), and Case Report / Case Series (17%).
Kushwaha AC (2026). [PMID: 40931580](https://pubmed.ncbi.nlm.nih.gov/40931580/). *Adv Healthc Mater*. [Gene Therapy / Novel Therapeutics]
Kushwaha AC (2025). [PMID: 39711012](https://pubmed.ncbi.nlm.nih.gov/39711012/). *ACS Appl Mater Interfaces*. [Basic Science / Preclinical]
Cai J (2025). [PMID: 40040976](https://pubmed.ncbi.nlm.nih.gov/40040976/). *Heliyon*. [Case Report / Case Series]
Li G (2025). [PMID: 39774789](https://pubmed.ncbi.nlm.nih.gov/39774789/). *Sci Rep*. [Epidemiology / Natural History]
Chiarella E (2024). [PMID: 39436449](https://pubmed.ncbi.nlm.nih.gov/39436449/). *Cell Tissue Res*. [Review / Meta-Analysis]
Barneh F (2024). [PMID: 39113654](https://pubmed.ncbi.nlm.nih.gov/39113654/). *Haematologica*. [Gene Therapy / Novel Therapeutics]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:47 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acute myeloid leukemia with t(9;11)(p22;q23)